Drug Type Small molecule drug |
Synonyms Anseculin hydrochloride, Ensaculin, KA-672 HCL |
Mechanism 5-HT1A receptor agonists(Serotonin 1a (5-HT1a) receptor agonists), NMDA receptor antagonists(Glutamate [NMDA] receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC26H33ClN2O5 |
InChIKeyXMONKHCPLIYQCY-UHFFFAOYSA-N |
CAS Registry209969-60-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Ensaculin Hydrochloride | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Phase 3 | DE | - | |
Alzheimer Disease | Phase 3 | - | - |